Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1996-03-01
1998-10-27
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514161, 424 9464, A61K 3170
Patent
active
058278320
ABSTRACT:
The invention is directed to a method of reducing the extent of infarction, particularly cerebral infarction subsequent to cerebral ischemia, by the administration of citicoline shortly after an ischemic episode and continuing daily treatment for up to about 30 days, preferably for at least about 6 weeks. The method is useful in the treatment of stroke and severe head trauma patients and maximizes the chances for a full or substantially full recovery of the patient. Combination treatment regimens are also disclosed along with compositions for use therewith.
REFERENCES:
patent: 4386078 (1983-05-01), Horrocks et al.
HCAPLUS Abstract 1988: 143195, Kakihana et al.(1988).
Longa, Zea et al., Stroke (1989) 20:84-91.
The Ancrod Study Investigators, Stroke (1994) 25:1755-1759.
Budavari et al., The Merck Index (11th Ed.) pp. 361-362 (1989).
Rossi, M. et al., Medline Abstract 93230870 (Feb. 1993).
Canino, V. et al., Medline Abstract 80188636 (1980).
Giratto, T. et al., Embasse Abstract 71026199 (1980).
Kaste, M. et al. Stroke (1994) 25:1348-1353.
Olney, J.W. et al. Science (1991) 254:1515-1518.
Kinouchi, H. et al. Proc. Natl. Acad. Sci. USA (1991) 88:11158-11162.
Diener, H.C. et al. Stroke (1995) 26:30.
Bell, R.D. et al. Stroke (1991) 22:80-83.
del Zoppo, G.J. et al. Seminars in Neurology (1991) 11(4): 368-384.
The Ancrod Stroke Study Investigators, Stroke (1994) 25:1755-1759.
Hacke, W. et al. Stroke (1995) 26:167.
Ulus, I.H. et al. Brain Research (1989) 484:217-227.
Altman R. et al. British Medical Journal (1994) 308:81-106.
The Canadian Cooperative Study Group, New England Journal of Medicine (1978) 299:53-59.
The ESPS Group, "The European Stroke Prevention Study," (1990) Stroke 21:1122-1130.
Minematsu, K. et al. Cerebrovasc. Dis. (1993) 3:99-104.
Schabitz, W. et al. Journal of the Neurological Sciences (1996) 138:21-25.
D'Orlando, K.J. et al. Neurological Research (1995) 17:281-284.
Abstract: "Effects of Citicoline on infarct volume, mortality and behavioral outcome after temporary local ischemia" by: Johannes Weber et al., dated: Jan. 9, 1995, European Stroke Conference, Bordeaux, France Jun. 1-3, 1995.
Kogure, K., et al., Annals of Neurology, vol. 8, No. 3, Sep. 1980, pp. 278-290.
Grosset, D.G., et al., Journal of Cardiovascular Pharmacology, vol. 25, No. 5, 1995, pp. 705-709.
Lo, Eng H., Neuroscience Letters, 131, (1991), pp. 17-20.
Tuor, U.I., et al., Stroke, vol. 24, No. 3, Mar. 1993, pp. 452-457.
Grotta, James, Stroke, vol. 18, No. 1, Jan.-Feb. 1987, pp. 264-267.
Ochiai, Chikayuki, et al., Stroke, vol. 13, No. 6, Nov.-Dec. 1982, pp. 788-796.
Barinaga, Science, vol. 272, May 3, 1996, pp. 664-666.
Demeurisse, G., et al., Stroke, vol. 14, No. 1, Jan.-Feb. 1983, pp. 77-81.
Windholtz et al. (eds.), The Merck Index, 19.sup.th Ed., Merck & Co., Inc. Rahway, NJ, 1983, entry 2290 at p. 329.
Makishima et al., "Treatment of Sensory-Neural Deafness and Tinnitus with a Nucleic Acid Derivative," Arzeneimittel Forsch. Dtsh., 21,(9),1343-1349 (1971).
Nilsson, "CDP-Choline-A Short Review," Clin. Pharmacol. Drug Epidemiol. 2, 273-277 (1979).
Phuong et al., "Nouvell Methode de Preparation de al Cytidine Diphosphate Choline (CDE Choline)", Bull. Soc. Chim. Fr. Pt. II., 1979(9-10), 518-519.
Gannaro et al. (eds.), Remmington's Pharmaceutical Sciences, 18.sup.th ed., Mack Publishing Co., Easton, PA, 1990, see pp. 867, 1014 and 1026 as marked.
Sanchez et al., "CDP-Choline:Physico-Chemical Characteristics," Arzneimittel Forschung-Drug Research, 33(II), 1011-1012(1983).
Algate et al., "Study of the Effects of Oral Administration of CDP-Choline on EEG Changes and Lethality Induced by Epidural Compressions in the Anaethestized Cat." Arzneimittel Forschung-Drug Research, 33(II), 1013-1016(1983).
Agut et al.(I), "Dissimilar Effects in Acute Toxicity Studies of CDP-Choline and Choline," Arzneimittel Forschung-Drug Research, 33(II), 1016-1018(1983).
Braso et al., "Action of CDP-Choline by Intraduodenal Route on Rat Cardiorespitory System," Arzneimittel Forschung-Drug Research, 33(II), 1043-1045(1983).
Agut et al. (II, "Bioavailability of Methyl--.sup.14 C CDP-Choline and Choline by Oral Route." Arzneimittel Forschung-Drug Research, 33(II), 1045-1047(1983).
Agut et al. (III), "Radioactivity Incorporation into Different Cerebral Phospholipids after Oral Administration of .sup.14 C Methyl CDP-Choline," Arzneimittel Forschung-Drug Research, 33(II), 1048-1050(1983).
Aguilar et al., "Cerebral Subcellular Distribution of CDP-Choline and/or its Metabolites after Oral Administration of Methyl-.sup.14 C CDP-Choline," Arzneimittel Forschung-Drug Research, 33(II), 1051-1053(1983).
Romero et al.(I), "Low-Resolution Autoradiography in Rat Brain after Administering Labeled CDP-Choline Administration," Arzneimittel Forschung-Drug Research, 33(II), 1054-1056(1983).
Romero et al.(II), "High-Resolution Autoradiography in Mouse Brain 24 h after Radiolabelled CDP-Choline Administration," Arzneimittel Forschung-Drug Research, 33(II), 1056-1058(1983).
Romero et al.(III), "High-Resolution Autoradiography in Mouse Brain and Cerebellum 10 days after Radiolabelled CDP-Choline Administration," Arzneimittel Forschung-Drug Research, 33(II), 1058-1060(1983).
Dinsdale et al. (I), "CDP-Choline: Repeated Oral Dose Tolerance Studies in Adult Healthy Volunteers," Arzneimittel Forschung-Drug Research, 33(II), 1061-1065(1983).
Arrannz et al. "Treatment of Chronic Dyskinesia with CDP-Choline," Arzneimittel Forschung-Drug Research, 33(II), 1071-1073(1983).
Tornos et al. (I), "Effect of Oral CDP-Choline on Experimental Withdrawal Syndrone," Arzneimittel Forschung-Drug Research, 33(II), 1018-1021(1983).
Tornos et al. (II), "Pharmacological Study of CDP-Choline," Arzneimittel Forschung-Drug Research, 33(II), 1022-1024(1983).
Grau et al.(I), "Study on the Protection of CDP-Choline against Nicotine Intoxification," Arzneimittel Forschung-Drug Research, 33(II), 1025-1026(1983).
Tornos et al. (III), "Pharmacological Study of Oral CDP-Choline," Arzneimittel Forschung-Drug Research, 33(II), 1026-1029(1983).
Agut et al. (IV), "Effect of Oral CDP-Choline on Acrylamide-induced Lesion." Arzneimittel Forschung-Drug Research, 33(II), 1029-1033(1983).
Grau et al. (II), "CDP-Choline: Acute Toxicity Study," Arzneimittel Forschung-Drug Research, 33(II), 1033-1034(1983).
Romero et al. (IV), "Study of Subacute Toxicity of CDP-Choline after 30 days of Oral Administration to Rates," Arzneimittel Forschung-Drug Research, 33(II), 1035-1038(1983).
Romero et al. (V), "CDP-Choline: 6-Month Study on Toxicity in Dogs," Arzneimittel Forschung-Drug Research, 33(II), 1038-1042(1983).
Dinsdale et al. (II), "Pharmacokinetics of .sup.14 C CDP-Choline," Arzneimittel Forschung-Drug Research, 33(II), 1066-1070(1983).
Fernandez, "Efficacy and Safety of Oral CDP-Choline," Arzneimittel Forschung-Drug Research, 33(II), 1073-1080(1983).
Table of Contents, Key Word Index and Preface.sup.a (J.A. Ortiz) Introducing the Series of Papers on Cytidine Diphosphate Choline, Arzneimittel Forschung-Drug Research, 33(II), 1009-1010.sup.a (1983) and preceding pages.
Fukunaga et al. (I). "Hypotensive Effects of Adenosine and Adenosine Triphosphate Compared with Sodium Nitroprusside," Anesthesia and Analgesia, 61(3), 273-278 (1982).
Trovarelli, G. et al., "Effect of Cytidine on the Modification of Phospholipid Metabolism Induced by Ischemia", Neurochemical Research, vol. 12, No. 3, 1987, pp. 227-235.
Trovarelli, G. et al., "The Influence of Cytidine on the Endogenous Pool of CDP-Choline, CDP-Ethanolamine, and CMP of the Rat Brain", Neurochemical Research, vol. 9, No. 1, 1984, pp. 73-79.
Trovarelli, G. et al., "The Transport of Cytidine into Rat Brain In Vivo, and its Conversion into Cytidine Metabolites", Neurochemical Research, vol. 7, No. 10, 1982, pp. 1199-1207.
De Medio, G.E. et al., "The Effect of Cytidine-Diphosphate Choline (CDP-Choline) on Brain Lipid changes During Aging", Journal of Neuroscience Research, 11:49-58 (1984).
Petkov, V.D. et al., "Effects of Cytidine Diphosphate Choline on Rats with Memory Deficits", Institute of Phisiology, Bulgarian Academy of Science, Sofia, Bulgaria (first page
Fisher Marc
Locke Kenneth W.
Sandage, Jr. Bobby W.
Interneuron Pharmaceuticals Inc.
Moezie M.
Villacorta Gilberto M.
Weddington Kevin E.
LandOfFree
Method of protecting brain tissue from cerebral infarction subse does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of protecting brain tissue from cerebral infarction subse, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of protecting brain tissue from cerebral infarction subse will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1613960